Fractionated Dosing of CLR 131 in Patients with Relapsed or Refractory Multiple Myeloma Presented at the 61st Annual American Society of Hematology Conference
Stock Information for Cellectar Biosciences Inc.
Loading
Please wait while we load your information from QuoteMedia.